Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69.35 EUR | +1.31% | -7.31% | -12.91% |
Apr. 26 | COMPUGROUP MEDICAL : Buy rating from Baader Bank | ZD |
Apr. 25 | COMPUGROUP MEDICAL : Jefferies gives a Neutral rating | ZD |
Sales 2024 * | 1.24B 1.33B | Sales 2025 * | 1.3B 1.39B | Capitalization | 1.49B 1.6B |
---|---|---|---|---|---|
Net income 2024 * | 93M 99.66M | Net income 2025 * | 117M 125M | EV / Sales 2024 * | 1.72 x |
Net Debt 2024 * | 641M 687M | Net Debt 2025 * | 556M 595M | EV / Sales 2025 * | 1.58 x |
P/E ratio 2024 * |
16
x | P/E ratio 2025 * |
12.8
x | Employees | - |
Yield 2024 * |
2.32% | Yield 2025 * |
2.58% | Free-Float | 46.87% |
Latest transcript on CompuGroup Medical Societas Europaea
1 day | +1.31% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Rauch
CEO | Chief Executive Officer | 52 | 19-07-31 |
Frank Gotthardt
CEO | Chief Executive Officer | 72 | 86-12-31 |
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Director/Board Member | 59 | 20-06-17 | |
Klaus Esser
BRD | Director/Board Member | - | 03-05-25 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.17% | 322B | |
+24.75% | 216B | |
+2.41% | 149B | |
+10.65% | 56.27B | |
+8.71% | 32.13B | |
-4.57% | 27.45B | |
+103.03% | 22.62B | |
+21.40% | 19.55B | |
+13.06% | 14.69B |
- Stock Market
- Equities
- COP Stock
- COP Stock